Allergan Breast Implants Recalled Today, July 24, 2019. Dr. Kaveeta Vashisht, Acting Associate Commissioner for the FDA Office of Women’s Health, alerted women’s health care professionals that the FDA has requested Allergan to recall certain breast implants and tissue expanders to protect patients from associated health risks. Specifically, the FDA’s action seeks to protect women from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) associated with the use of Allergan’s BIOCELL textured breast implants and tissue expanders.
Allergan Breast Implants Recalled – Product Information
As the result of the FDA’s request, Allergan has agreed to a worldwide recall of the Company’s BIOCELL textured breast implant products, including:
• Natrelle Saline-Filled breast implants;
• Natrelle Silicone-Filled breast implants;
• Natrelle Inspira Silicone-Filled breast implants and;
• Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled breast implants.
The recall also includes tissue expanders used by patients prior to breast augmentation or reconstruction including:
• Natrelle 133 Plus Tissue Expander and ;
• Natrelle 133 Tissue Expander with Suture Tabs.
The FDA has also issued a safety communication for breast implant patients, those considering breast implants, and their health care providers detailing the risks; and what steps patients should consider when monitoring for symptoms of BIA-ALCL, including swelling and pain in their breasts.
Breast Implant Lawsuit Information
If you have suffered injuries related to recalled Allergan Breast Implants you may be able to seek compensation based on the manufacturer’s failure to properly design these products, or to adequately warn patients and doctors of breast implant complications. If you or a loved one would like more information regarding Breast Implant Lawsuits, please call our firm toll free at 1-877-934-6274. We promise to bring our more than 35 years of experience representing personal injury victims to bear on your behalf.
